# OnCo record tempus-xr (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/tempus-xr/>
  a schema:MedicalTest ;
  onco:kind "drug" ;
  schema:identifier "tempus-xr" ;
  schema:name "Tempus xR"@en ;
  schema:alternateName "Tempus xR IVD"@en, "xR IVD"@en, "xR" ;
  schema:description "A tumour RNA sequencing test from Tempus, usually run with its DNA panel, that finds gene fusions DNA testing can miss."@en ;
  schema:url <https://onco.cc/drugs/tempus-xr/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K241868>, <https://www.accessdata.fda.gov/cdrh_docs/reviews/K241868.pdf> ;
  onco:status "approved" ;
  onco:tag "test", "rna" ;
  onco:modality "Tumour RNA sequencing test (fusion detection; FDA-cleared for BRAF and RET rearrangements)" ;
  onco:approval "US 2025: FDA 510(k) clearance (K241868) for detection of BRAF and RET rearrangements in RNA from solid tumour tissue" ;
  onco:related <https://onco.cc/drugs/tempus-xt-cdx/>, <https://onco.cc/drugs/tempus-xe/>, <https://onco.cc/drugs/foundationone-rna/> ;
  onco:technologies <https://onco.cc/technologies/rna-seq/>, <https://onco.cc/technologies/cgp/> ;
  onco:companies <https://onco.cc/companies/tempus/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-gai-rna-dna-ngs-fusions-cancer-res-commun-2025/> .